irinotecan has been researched along with Carcinoma, Lewis Lung in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belousov, MV; Gur'ev, AM; Lopatina, KA; Razina, TG; Sadrikina, LA; Safonova, EA; Zueva, EP | 1 |
| Colson, YL; Falde, EJ; Freedman, JD; Grinstaff, MW; Herrera, VL; Yohe, ST | 1 |
| Lesnaia, NA; Pokrovskiĭ, VS; Romanenko, VI; Treshchalina, EM | 1 |
| Ayuzawa, R; Doi, C; Maurya, DK; Tamura, M; Troyer, D | 1 |
| Saiki, I | 1 |
| Hirota, S; Hirotsu, S; Sadzuka, Y | 1 |
| Ikeda, T; Mitani, N; Murakami, K; Saiki, I; Yamaura, T | 1 |
7 other study(ies) available for irinotecan and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Correction of Damaging Effects of Cisplatin-Containing Polychemotherapy on the Intestinal Epithelium with Tussilago farfara L. Polysaccharides.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cisplatin; Eosine Yellowish-(YS); Etoposide; Female; Hematoxylin; Histocytochemistry; Intestinal Mucosa; Irinotecan; Mice; Mice, Inbred C57BL; Paclitaxel; Plant Extracts; Polysaccharides; Tussilago | 2019 |
Layered superhydrophobic meshes for controlled drug release.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Lewis Lung; Cell Line, Tumor; Delayed-Action Preparations; Drug Delivery Systems; Hydrophobic and Hydrophilic Interactions; Irinotecan; Neoplasm Recurrence, Local; Polyesters; Rats; Rats, Inbred Lew; Solubility; Surface Properties | 2015 |
[Pre-clinical study of combined aranosa, cisplatin and irinotecan in the treatment of experimental lung cancer].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Lewis Lung; Cisplatin; Drug Administration Schedule; Glycosides; Irinotecan; Male; Methylnitrosourea; Mice; Mice, Inbred C57BL; Mice, Inbred Strains | 2009 |
Topoisomerase I inhibitor SN-38 effectively attenuates growth of human non-small cell lung cancer cell lines in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Camptothecin; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Humans; Irinotecan; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Poly(ADP-ribose) Polymerases; Topoisomerase I Inhibitors | 2011 |
[Screening for inhibitors of tumor invasion into basement membranes].
Topics: Animals; Basement Membrane; Berberine; Camptothecin; Carcinoma, Lewis Lung; Cell Movement; Drug Screening Assays, Antitumor; Humans; Irinotecan; Lymphatic Metastasis; Mice; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Saponins; Tumor Cells, Cultured | 2004 |
Effective irinotecan (CPT-11)-containing liposomes: intraliposomal conversion to the active metabolite SN-38.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biotransformation; Camptothecin; Carcinoma, Lewis Lung; Drug Carriers; Irinotecan; Liposomes; Male; Mice; Tissue Distribution | 1999 |
Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Berberine; Camptothecin; Carcinoma, Lewis Lung; Disease Models, Animal; Female; Irinotecan; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Transplantation; Transcription Factor AP-1 | 2001 |